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We examined the risk of childhood cancer (o20 years) among 105950 offspring born in 1921–1984 to US radiologic technologist
(USRT) cohort members. Parental occupational in utero and preconception ionising radiation (IR) testis or ovary doses were
estimated from work history data, badge dose data, and literature doses (the latter doses before 1960). Female and male RTs
reported a total of 111 and 34 haematopoietic malignancies and 115 and 34 solid tumours, respectively, in their offspring. Hazard
ratios (HRs) and 95% confidence intervals (CIs) were calculated using Cox proportional hazards regression. Leukaemia (n¼63) and
solid tumours (n¼115) in offspring were not associated with maternal in utero or preconception radiation exposure. Risks for
lymphoma (n¼44) in those with estimated doses of o0.2, 0.2–1.0, and 41.0mGy vs no exposure were non-significantly elevated
with HRs of 2.3, 1.8, and 2.7. Paternal preconception exposure to estimated cumulative doses above the 95th percentile (X82mGy,
n¼6 cases) was associated with a non-significant risk of childhood cancer of 1.8 (95% CI 0.7–4.6). In conclusion, we found no
convincing evidence of an increased risk of childhood cancer in the offspring of RTs in association with parental occupational radiation
exposure.
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Exposure to in utero diagnostic ionising radiation (IR) is generally
considered to increase the risk of childhood cancer, including solid
and haematological malignancies (Brenner et al, 2003; Wakeford,
2004). Although cohort studies of medical radiation workers have
reported increases in the incidence and mortality of skin cancer,
breast cancer, and leukaemia, especially in individuals who started
working before 1950 when both radiation doses and permitted
levels of exposure were higher (Yoshinaga et al, 2004), the risk of
cancer in their offspring associated with parental occupational
exposure is unclear (Brenner et al, 2003). Radiation could increase
offspring cancer risk through germline or in utero somatic
mutations (Doll and Wakeford, 1997; UNSCEAR, 2001; Prasad
et al, 2004). The only study of childhood cancer incidence in the
offspring of medical radiographers found no significant excess
(Roman et al, 1996).
The US radiologic technologist (USRT) cohort is one of the
largest groups of occupationally exposed medical personnel
assembled for study. As 73% USRT cohort participants are female,
both preconception and in utero occupational radiation exposure
effects on offspring cancer risk could be studied. In addition, much
effort was devoted to reconstructing probable dose levels during
periods when workers were not routinely monitored (Simon et al,
2006), allowing quantitative evaluation of parental exposures. To
date, this is the largest study of childhood cancer risk in RT
offspring.
METHODS
The University of Minnesota Institutional Review Board and the
United States National Cancer Institute approved all protocols for
data use. Complete study details have been described elsewhere
(Boice et al, 1992; Doody et al, 1998; Mohan et al, 2002, 2003;
Freedman et al, 2003; Sigurdson et al, 2003). Briefly, three
questionnaires were mailed to individuals registered with the
American Registry of Radiologic Technologists during 1983–89,
1994–98, and 2004–08. The initial questionnaire was sent to
132454 RTs and returned by 90305 of them, a response rate of
68%, whereas 83% of RTs (70859 out of 85372) who responded to
the first questionnaire returned the second one of which 132118
offspring were enumerated. The following information was
reported on the second questionnaire for up to eight of their
children: gender; birth year; the occurrence of cancer (no, yes, do
not know) and its type (leukaemia, lymphoma, brain, or ‘other,
specify’; the latter detail was entered into the data file verbatim);
diagnosis year; vital status; and death year. We excluded offspring
who were born after 1984 (n¼23123; the latest year for which
estimated doses were available); had missing, incomplete, or
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year, or death year (n¼2859); had reported Down’s syndrome
(n¼123); or had an ‘other cancer’ reported as a condition of the
skin (other than sarcoma) or the cervix (n¼73) occurring during
childhood (o20 years), to eliminate potentially benign common
conditions of these tissues (e.g., moles and abnormal pap smears).
The resultant data set included 81262 and 24678 offspring of
female and male RTs, respectively.
Annual occupational radiation doses received by RTs were
estimated as described previously (Simon et al, 2006), using
all relevant literature on doses received by RTs (mainly for
those working before 1960, when dosimetry was not available),
film-badge measurements from a commercial dosimetry provider
or military dose registries, dose records provided by employers,
and individual work history and protection practices from
three cohort surveys. Annual ovary and testes organ dose estimates
were used as the best approximations for foetal and germline
exposures. The estimated in utero exposure dose was defined
as the average of the ovarian doses in the year before and the
year of birth, as only the year of birth rather than the date
of birth was collected. The estimated preconception dose
was calculated as the sum of annual testes or ovary dose
estimates up to the year before birth to avoid overlap with the
in utero period.
Statistical analyses
Hazard ratios (HRs) and 95% confidence intervals (CIs) were
calculated by Cox proportional hazards regression (SAS version
9.1; Cary, NC, USA). Person-time was calculated as the interval
between the reported birth year and the cancer diagnosis year,
death year, the year the child turned age 19, or the year that the
second questionnaire was completed, whichever came first. A
person-time of 0.5 years was assigned to those who were censored
or had an event in their birth year. All regression analyses were
stratified by the gender of the parent.
Average cancer incidence rates per million person-years
were determined for each age group in years (0–4, 5–9, 10–14,
15–19) as the number of events per person-years. The ratio of
observed to expected numbers (the standardised incidence ratio
(SIR)) was calculated for RT parent and child gender strata
for childhood leukaemia, lymphoma, and all sites by applying
the sex-specific incidence rates obtained from two registries:
(1) Surveillance, Epidemiology, and End Results (SEER) 9
(1973–2004) (SEER, 2007) and (2) Connecticut historical registry
(rates available from 1935 to 1999) (SEER, 1999) to the
person-time distribution of the offspring cohort (Rothman and
Greenland, 1998). For the SEER registry comparison, rates
for person-time for years before 1973 were compared to SEER
incidence rates for 1975–76, the earliest period with complete
data (SEER, 2007). Only subjects whose parents were reported to
be white were ncluded due to the small number of other races.
Exposures were modelled as categorical variables with P-values
for tests for linear trend calculated by inclusion of the continuous
measure of dose in regression models. Estimated in utero
dose exposures were categorized as follows: 0mGy (reference),
40–0.17mGy, 0.18–1.0mGy, and 0.01–12.6mGy. Estimated pre-
conception ovarian and testes dose exposures were categorized
according to quartiles: o0.43mGy, 0.43–1.49mGy, 1.50–3.57mGy,
43.57mGy; testes: o0.67, 0.67–4.92, 4.93–15.26, 415.27) with
additional analyses for the offspring of males that divided the
fourth quartile at the 95th percentile (481.92mGy).
For the offspring of female RTs, results are reported for the
following childhood cancer outcomes: (1) leukaemia, (2) lympho-
ma, (3) solid tumours, and (5) all childhood cancers. Owing to the
small number of childhood cancer cases reported by male RTs
(n¼68), results are given for haematological malignancies
(leukaemia and lymphoma), solid tumours, and overall childhood
cancers only.
RESULTS
Characteristics of all RTs and those with eligible children who
responded to both the baseline and second questionnaires are
provided in Supplementary Table 1. The majority of RT
respondents were female (79%), born during 1941–1960 (78%),
first employed during 1961–1980 (79%), and reported having had
at least one child (80%) with a median of two children.
The characteristics of the offspring are presented in Table 1.
The majority of offspring were born between 1960 and 1980 with
slightly more male than female offspring, and a more pronounced
male excess in cases of leukaemia (58% male) and lymphoma (72%
male) (data not shown). The mean estimated in utero and
Table 1 Characteristics of offspring of members of the USRT cohort (n¼104461)
a
Birth year cohort of offspring
All years 1921–1930 1931–1940 1941–1950 1951–1960 1961–1970 1971–1980 1980–1984
No. of offspring of female RTs 80396 (226) 19 (0) 178 (0) 1420 (2) 9131 (36) 23251 (77) 31232 (79) 15165 (32)
% Male 51 (54) 63 (0) 54 (0) 52 (50) 51 (67) 51 (49) 51 (53) 51 (53)
Mean in utero dose, mSV 0.2 (0.3) 0 (ND) 0.7 (ND) 0.4 (0) 0.6 (0.7) 0.1 (0.1) 0.2 (0.3) 0.2 (0.1)
Mean preconception dose, mSV 3.4 (3.4) 0 (ND) 8.1 (ND) 9.0 (0) 7.8 (5.4) 4.2 (4.1) 1.9 (2.5) 2.2 (1.5)
% Female 49 (46) 37 (0) 47 (0) 48 (50) 49 (33) 49 (51) 49 (47) 49 (47)
Mean in utero dose, mSV 0.2 (0.2) 0.7 (ND) 0.8 (ND) 0.4 (0) 0.6 (0.4) 0.1 (0.1) 0.2 (0.2) 0.2 (0.1)
Mean preconception dose, mSV 3.5 (2.8) 4.9 (ND) 9.5 (ND) 9.3 (18.1) 8.1 (5.2) 4.2 (2.7) 2.0 (2.1) 2.2 (2.0)
No. of offspring of male RTs 24065 (68) 0 (0) 50 (0) 977 (3) 3972 (13) 6668 (23) 8828 (23) 3570 (6)
% Male 52 (60) 0 (0) 52 (0) 49 (67) 52 (62) 52 (83) 52 (43) 52 (33)
Mean preconception dose, mSV 17 (20) — 42 (ND) 43 (0) 38 (40) 18 (24) 6.9 (3.1) 8.9 (14.2)
% Female 48 (40) 0 (0) 48 (0) 51 (33) 48 (38) 48 (17) 48 (57) 48 (67)
Mean preconception dose, mSV 17 (13) — 51 (ND) 39 (58) 37 (38) 19 (6.9) 7.4 (4.0) 8.3 (4.3)
ND¼not determined; USRT¼US radiologic technologist. Corresponding case statistics are shown in parentheses.
a1489 subjects had missing data on gender.
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generally decreased over time, declining approximately four- to
sixfold from the 1930s through the 1970s and 1980s. Estimated
doses were generally low and similar between cases and all subjects.
Approximately 96% of cases and 95% of non-cases had parents
who reported being white. Cases and non-cases were similar with
respect to birth order (48% of cases vs 46% of non-cases reported
having a birth order of 1). Overall, case parents tended to be
younger (o30 years) than non-case parents at the time of the
offspring’s birth (79 vs 73%) (data not shown).
In total, 294 offspring had reported cancers diagnosed at
o20 years of age (Table 2). Leukaemia (n¼94), lymphoma
(n¼61), and central nervous system (CNS) tumours (n¼46)
were the most common cancer types. The peak leukaemia
incidence occurred at o5 years of age with rates of 72 and 97
cases per million person-years in female and male RT
offspring, respectively. Peak lymphoma incidence occurred in
older children, with the highest rate being in 15- to 19-year olds.
Central nervous system tumour rates did not show marked
variation by age in the offspring of female RTs. The pattern for the
offspring of male RTs was less consistent, presumably due to the
small number of cases (n¼12).
No significant increase in risk or dose–response was found for
leukaemia, lymphoma, solid tumours, or childhood cancer overall
in association with in utero radiation exposure (Table 3). Based on
48 cases of lymphoma, the HR was increased approximately two-
to threefold for all dose categories above the reference with no
apparent linear trend (P¼0.32).
No appreciable increased risk or dose–response was
observed between maternal preconception exposure and
Table 2 Age-group-specific childhood cancer rates per million person-years (n) reported by USRT cohort members by age group (n¼105940)
Offspring of female age group (years) Offspring of male age group (years)
0–19 0–4 5–9 10–14 15–19 0–19 0–4 5–9 10–14 15–19
Haematological malignancies 77 (111) 86 (37) 75 (30) 57 (21) 84 (25) 76 (34) 122 (15) 49 (6) 44 (5) 83 (8)
Leukaemia 33 (63) 72 (29) 52 (21) 19 (7) 20 (6) 47 (21) 97 (12) 49 (6) 0 (0) 31 (3)
Lymphoma 44 (48) 15 (6) 22 (9) 38 (14) 64 (19) 29 (13) 24 (3) 0 (0) 44 (5) 52 (5)
Solid tumours 80 (115) 116 (47) 50 (20) 52 (17) 97 (31) 76 (34) 89 (11) 25 (3) 61 (7) 134 (13)
CNS 37 (34) 25 (10) 22 (9) 25 (9) 20 (6) 36 (12) 24 (3) 8 (1) 26 (3) 52 (5)
Neuroblastoma 11 (16) 35 (14) 5 (2) 0 (0) 0 (0) 2 (1) 8 (1) 0 (0) 0 (0) 0 (0)
Kidney/Wilms’ tumour 10 (14) 25 (10) 10 (4) 0 (0) 0 (0) 4 (2) 16 (2) 0 (0) 0 (0) 0 (0)
Retinoblastoma 4 (6) 15 (6) 0 (0) 0 (0) 0 (0) 11 (5) 32 (4) 8 (1) 0 (0) 0 (0)
Thyroid cancer 4 (6) 0 (0) 0 (0) 0 (0) 6 (20) 2 (1) 0 (0) 0 (0) 0 (0) 10 (1)
Other solid tumours
a 27 (39) 17 (7) 12 (5) 27 (10) 57 (17) 29 (13) 8 (1) 8 (1) 35 (4) 72 (7)
Total childhood cancers 156 (226) 202 (82) 125 (50) 109 (38) 181 (56) 158 (68) 211 (26) 74 (9) 105 (12) 227 (21)
CNS¼central nervous system; USRT¼US radiologic technologist. The numbers in parentheses are the number of cases in each age group.
aOther solid tumours included
reported offspring cancers: appendix (n¼1), bone (n¼4), breast (n¼1), bladder (n¼1), colon (n¼1), Ewing’s sarcoma (n¼4), germ-cell tumours (n¼3), leiomyosarcoma
(n¼1), liver tumours (n¼2), lung pulmonary blastoma (n¼1), oral (n¼1), ovarian (n¼2), pancreas (n¼1), parotid gland (n¼2), primitive neural ectodermal tumours (n¼2),
rhabdomyosarcoma (n¼5), soft tissue sarcoma (n¼2), other sarcomas (n¼8), stomach (n¼1), teratoma (n¼2), testicular cancer (n¼4), and uterine (n¼3).
Table 3 Cox proportional hazards regression modelling of the association between in utero IR exposure and childhood cancer in the offspring of female
RTs (n¼81262)
Cancer type Person-years Cases HR
a 95% CI P-trend
Leukaemia
0mGy 637994 28 1.0 ref.
40–0.17mGy 369381 17 1.1 0.6–2.0
0.18–1.0mGy 381244 15 0.9 0.5–1.8
1.01–12.6mGy 56252 3 1.1 0.3–3.7 0.72
Lymphoma
0mGy 637994 14 1.0 ref.
40–0.17mGy 369381 16 2.3 1.1–4.9
0.18–1.0mGy 381244 14 1.8 0.9–3.9
1.01–12.6mGy 56252 4 2.7 0.9–8.7 0.32
Solid tumours
0mGy 637994 51 1.0 ref.
40–0.17mGy 369381 30 1.0 0.6–1.6
0.18–1.0mGy 381244 29 0.9 0.6–1.5
1.01–12.6mGy 56252 5 1.2 0.5–3.1 0.44
Childhood cancers overall
0mGy 637994 93 1.0 ref.
40–0.17mGy 369381 63 1.2 0.9–1.7
0.18–1.0mGy 381244 58 1.1 0.8–1.5
1.01–12.6mGy 56252 12 1.4 0.8–2.6 0.41
CI¼confidence interval; HR¼hazard ratio; IR¼ionising radiation; RT¼radiologic technologist.
aAdjusted for birth year.
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95th percentile (482mGy) were associated with a non-significant
increased risk of 1.8 (95% CI 0.7–4.6) relative to the
reference group, on the basis of six events (two leukaemia, two
lymphoma, one sarcoma, and one oral cancer case) (Supplemen-
tary Table 2).
Standardised incidence ratios were calculated for leukaemia,
lymphoma, or all reported childhood cancer rates in the offspring
of RTs relative to SEER and Connecticut registry rates (Table 4).
Cancer incidence was not increased in RT offspring for all sites
combined or leukaemia. The incidence of lymphoma was increased
in the male offspring of both female and male RTs relative to both
population registries with SIRs between 1.6 and 1.7.
DISCUSSION
Overall, our results do not support an increased risk of childhood
cancer in the offspring of RTs associated with occupational IR
exposure while in utero or before conception. An increased risk
of lymphoma was observed based on a small number of cases
but there was no dose–response. Our data do not indicate an
association between maternal preconception radiation exposure
and offspring childhood cancers. A non-significant increased
risk of childhood cancer was associated with paternal preconcep-
tion exposure only above the 95th percentile (482mGy), based on
few cases.
In utero exposure to maternal occupational medical radiation
did not markedly increase the risk of any of the childhood cancer
outcomes examined except lymphoma. A small increase of
approximately 40% in the risk of childhood cancer is thought to
be detectable for acute exposure to diagnostic in utero radiation at
doses in the range of 10mGy, based on results from case–control
studies of subjects born between late 1940s and early 1980s
(Doll and Wakeford, 1997). The offspring of RTs in our study
were generally exposed to lower doses, with the highest estimated
dose for cases being 3.3mGy, for a subject with a reported
brain tumour. The estimated mean in utero dose for lymphoma
cases was 0.3mGy, which is approximately 10-fold lower than
average annual background radiation exposure (Wakeford, 2004)
and, therefore, it is unlikely that maternal occupational radiation
exposure explains the increased lymphoma risk.
Consistent with our results, most previous studies have
not provided strong support for an association between childhood
cancer and parental preconception exposures to either low or high
doses of atomic bomb radiation (Izumi et al, 2003a,b), medical or
nuclear occupational radiation (Kinlen et al, 1993; McLaughlin
et al, 1993; Roman et al, 1993, 1996; Draper et al, 1997; Pobel and
Viel, 1997), or therapeutic or diagnostic medical radiation (Kallen
et al, 1998; Sankila et al, 1998; Little, 1999; Shu et al, 2002;
Patton et al, 2004; Nagarajan and Robison, 2005). A notable
exception (Gardner et al, 1990) examined the incidence of
leukaemia/non-Hodgkin’s lymphoma (LNHL) diagnosed at an
age of o25 years in individuals living near the Sellafield nuclear
facility in England, which included 74 cases of LNHL (14 in the
offspring of fathers employed at Sellafield). A significant increased
risk of 6.4 for LNHL was reported in association with paternal
cumulative preconception radiation dose 4100mSV on the basis
of 4 exposed cases. The case excess was largely confined to the
neighbouring village of Seascale (Cumbria, England). Subsequent
independent investigations conducted in England, France,
Scotland, and Canada have failed to support this association
(Kinlen et al, 1993; McLaughlin et al, 1993; Draper et al, 1997; Pobel
and Viel, 1997). The alternative hypothesis for Gardner’s findings of
population mixing (Kinlen, 1988) has been supported by several
studies (Little, 1999; McNally and Eden, 2004).
Excess in cases of lymphoma in the male offspring of those
exposed to radiation has not been previously reported. No male
excess has been reported in association with in utero diagnostic
radiation exposure in two of the largest studies: the Oxford Survey
of Childhood Cancers (Bithell and Stewart, 1975) and the
North-eastern United States study (Monson and MacMahon,
1984), or in the offspring of atomic bomb survivors who were
exposed while in utero (Delongchamp et al, 1997).
Our study addresses the important issue of cancer risk in
the offspring of medical radiation workers, particularly females,
who are exposed to low-level protracted occupational radiation.
Prior data comes mainly from studies of cancer risk in offspring
of nuclear workers who are predominantly male. However, as with
all studies of rare diseases and low-dose exposures, our study
has its own limitations. Electronic files of film-badge doses were
not routinely available until late 1970s. To estimate these doses, we
undertook a comprehensive dose reconstruction that used
hundreds of thousands of badge doses from electronic files from
1977 onward, thousands of badge doses from hard copy records
for the period 1960–76, and literature-based dose data for
the period before 1960 (Simon et al, 2006). This dose reconstruc-
tion, although imperfect, is likely to be superior to proxy measures
of exposure such as job title. A further limitation is that offspring
cancers were ascertained by parent report. Although medical
record validation is preferred, the potential success was judged to
be prohibitively low, given that many relevant diagnoses occurred
Table 4 Standardised incidence ratios comparing childhood cancer incidence rates in the offspring of RTs to SEER and Connecticut registry rates
(n¼100115)
a
Offspring of females Offspring of males
Males Females Males Females
O E O/E (95% CI) O E O/E (95% CI) O E O/E (95% CI) O E O/E (95% CI)
SEER registry comparison
Leukaemia 37 30 1.2 (0.9–1.7) 26 24 1.1 (0.7–1.6) 11 9 1.3 (0.6–2.2) 8 7 1.2 (0.5–2.4)
Lymphoma 33 20 1.7
b (1.2–2.4) 14 14 1.0 (0.6–1.7) 10 6 1.7 (0.8–3.1) 3 4 0.8 (0.2–2.2)
All sites 120 114 1.1 (0.9–1.3) 101 99 1.0 (0.8–1.2) 39 33 1.2 (0.8–1.6) 24 29 0.9 (0.5–1.3)
Connecticut registry comparison
Leukaemia 37 32 1.2 (0.8–1.6) 26 24 1.1 (0.7–1.6) 11 9 1.2 (0.6–2.1) 8 7 1.2 (0.5–2.3)
Lymphoma 33 21 1.6
b (1.1–2.2) 14 14 1.0 (0.5–1.7) 10 6 1.6 (0.8–2.9) 3 4 0.7 (0.2–2.1)
All sites 120 113 1.1 (0.9–1.3) 101 99 1.0 (0.8–1.2) 41 36 1.1 (0.8–1.5) 24 28 0.9 (0.6–1.3)
E¼expected; O¼observed; RT¼radiologic technologist; SEER¼Surveillance Epidemiology and End Results.
aExcludes data on 5826 subjects with missing gender or whose
parent reported a race other than white.
bPo0.05.
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However, the accuracy of parent-reported offspring cancers is
likely to be high based on the level of confirmation of diagnoses in
previous analyses (e.g., 98% of haematopoietic malignancies self-
reported by the technologists were confirmed in medical record
review) (Linet et al, 2005). Moreover, the absence of an overall
increase of cancer compared to rates from two different registries
suggests that over-reporting was not a substantial issue with the
caveat that conclusions from registry comparisons are limited by
differences in geographic coverage and study period.
Also, participation bias may have influenced our risk estimates.
In our experience, parents of children with cancer are more likely
to participate in studies than those with healthy children,
thereby tending to produce a greater than expected numbers of
cases. However, the overall childhood cancer rates in USRT
offspring were similar to the registry rates, suggesting that
participation bias did not substantially influence incidence
estimates. Participation could bias risk estimates if it was related
to both having a child with cancer and exposure level, although we
have no data to characterize the direction or magnitude of this
potential bias.
CONCLUSIONS
Although our sample size is insufficient to detect small increases in
risk, we can conclude with certainty that the risk of cancer is not
greatly increased in offspring of radiologic technologists.
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